A Smarter Way to Support Employee Wellness – and Lower Long-Term Health Costs
Help your team lose weight safely and sustainably with doctor-prescribed medications, expert coaching, and full accountability—while protecting your company from runaway GLP-1 costs.
Empower your team with a wellness benefit that actually changes lives. Tyde offers personalized, doctor-led program for sustainable weight loss that includes GLP-1 medications, expert nutrition and fitness coaching, and real-time support from a dedicated health coach.
Why Employers Are Turning to Tyde
GLP-1 medications are powerful, but without the right structure, support, and accountability, they become a costly short-term fix. Tyde ensures your employees are using them safely, effectively, and only as part of a long-term lifestyle change. Tyde partners with self-insured employers to ensure only committed employees gain access—and stay on track.
Doctor-Guided Care
Doctor-supervised dosing and medication oversight
Comprehensive Support Beyond Medication
Nutrition and fitness coaching built for sustainable results
Text-Based Coaching & Support
Direct access to reach your doctor or health coach anytime, anywhere.
Full Insurance Support
Optional requirement for prior auth approval through Tyde
Designed for Employers Who Care
Most wellness programs offer surface-level perks. Tyde delivers real change—backed by medical oversight, behavior coaching, and a plan for lasting results that protect your investment.
Improve productivity, focus, and retention
Decrease long-term healthcare claims and absenteeism
Attract and retain top talent by offering benefits that actually matter
Create a healthier, more energized workforce ready to perform

2.3x
ROI on structured weight loss programs that combine medical oversight with lifestyle interventions.

15%
Average body weight lost*

44%
Reduction in Cardiac-Related Hospitalizations
*After 68 weeks, participants administering once-weekly semaglutide treatment experienced an average of 15% reduction in body weight. The mean change in body weight from baseline to week 68 was −14.9% in the semaglutide group as compared with −2.4% with placebo. (Source)
Join the Thousands Seeing Incredible Results
Take the first step toward lasting health and well-being. Book a consultation today – we’ll guide you every step of the way.